Sancuso 3.1mg/24hr Transderm Patch

Manufacturer CUMBERLAND PHARMACEUTICALS Active Ingredient Granisetron Transdermal System(gra NI se tron) Pronunciation San-KOO-so (Granisetron: gra-NI-se-tron)
It is used to prevent upset stomach and throwing up.
đŸˇī¸
Drug Class
Antiemetic
đŸ§Ŧ
Pharmacologic Class
Selective 5-HT3 Receptor Antagonist
🤰
Pregnancy Category
Category B
✅
FDA Approved
Sep 2008
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Sancuso is a skin patch used to prevent nausea and vomiting that can happen after certain types of chemotherapy. It works by blocking a natural substance in your body that causes you to feel sick.
📋

How to Use This Medicine

Proper Use of Your Medication Patch

To use your medication patch correctly, follow the instructions provided by your doctor and read all accompanying information carefully. It is essential to use this medication as directed.

Application and Placement

Apply the patch only to your skin, avoiding oral ingestion.
Wash your hands before and after handling the patch.
Place the patch on clean, dry, and healthy skin on your upper arm.
Avoid applying the patch to irritated, damaged, or skin areas with recent cream, oil, lotion, powder, or other product use, as this may affect adhesion.
If hair is present at the application site, clip it close to the skin; do not shave.
Use only one patch at a time.

Patch Care and Maintenance

Do not cut, divide, or use damaged patches.
If the patch loosens, secure it with tape applied only to the edges.
Inform your healthcare provider if the patch becomes more than half detached or is damaged.
You can bathe or shower while wearing the patch, but avoid swimming, using a hot tub, or sauna.

Removal and Disposal

After removing the patch, fold the sticky sides together and discard it in a secure location inaccessible to children and pets.

Storage and Disposal

Store the patches at room temperature in a dry place, avoiding bathroom storage.

Missed Dose

* If you miss a dose or have questions about your medication schedule, contact your doctor for guidance.
💡

Lifestyle & Tips

  • Apply the patch to a clean, dry, intact area of skin on the upper outer arm. Do not apply to skin that is red, irritated, or scarred.
  • Rotate application sites to avoid irritation.
  • Do not cut the patch.
  • Avoid exposing the patch to direct heat sources (e.g., heating pads, electric blankets, saunas, prolonged hot baths/showers) as this can increase drug absorption.
  • The patch can be worn during showering, bathing, or swimming.
  • Remove the patch after 7 days, or sooner if chemotherapy is completed and antiemetic protection is no longer needed. Fold the patch in half with the sticky sides together and dispose of it safely, out of reach of children and pets.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: One 3.1 mg/24 hr transdermal patch applied to the upper outer arm 24 to 48 hours before chemotherapy, and worn for up to 7 consecutive days.
Dose Range: 3.1 - 3.1 mg

Condition-Specific Dosing:

chemotherapy_induced_nausea_vomiting: Apply 24-48 hours before chemotherapy, wear for 7 days.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment recommended.
Moderate: No dosage adjustment recommended.
Severe: No dosage adjustment recommended.
Dialysis: No specific recommendations; systemic exposure not significantly altered.

Hepatic Impairment:

Mild: No dosage adjustment recommended.
Moderate: No dosage adjustment recommended.
Severe: No dosage adjustment recommended.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Granisetron is a selective 5-hydroxytryptamine3 (5-HT3) receptor antagonist. Serotonin 5-HT3 receptors are located peripherally on vagal nerve terminals and centrally in the chemoreceptor trigger zone of the area postrema. Chemotherapy induces the release of serotonin from enterochromaffin cells of the small intestine, which then activates 5-HT3 receptors, initiating the vomiting reflex. Granisetron blocks this action, preventing nausea and vomiting.
📊

Pharmacokinetics

Absorption:

Bioavailability: Not directly quantifiable as a percentage for transdermal, designed for sustained release. Steady-state concentrations are achieved within 24-48 hours.
Tmax: Approximately 24-48 hours after patch application.
FoodEffect: Not applicable for transdermal patch.

Distribution:

Vd: Approximately 3 L/kg
ProteinBinding: Approximately 65%
CnssPenetration: Yes

Elimination:

HalfLife: Approximately 9 hours (after patch removal, due to continued absorption from skin depot)
Clearance: Approximately 40 L/hr
ExcretionRoute: Renal (urine) and Fecal (bile)
Unchanged: Approximately 12% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Within 24 hours of patch application (as steady-state levels are approached)
PeakEffect: Approximately 24-48 hours after patch application (corresponding to Tmax)
DurationOfAction: Up to 7 days while patch is worn, with continued effect after removal due to skin depot.

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out or changes in eyesight
Chest pain or pressure
Fast or abnormal heartbeat
Shortness of breath
Stomach pain
Swelling of the belly
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak

Additionally, a severe and potentially life-threatening condition called serotonin syndrome may occur, especially if you are taking certain other medications. Seek immediate medical attention if you experience:

Agitation
Changes in balance
Confusion
Hallucinations
Fever
Fast or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, upset stomach, or vomiting
Severe headache

Other Possible Side Effects

Like all medications, this drug may cause side effects in some people. While many individuals may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:

Headache
Dizziness, sleepiness, tiredness, or weakness
Diarrhea or constipation
Heartburn
Decreased appetite
Trouble sleeping
Irritation at the site of application

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe application site reactions (e.g., blistering, severe itching, swelling)
  • Signs of an allergic reaction (e.g., rash, hives, swelling of face/lips/tongue, difficulty breathing)
  • Symptoms of serotonin syndrome (e.g., agitation, confusion, rapid heart rate, fever, muscle stiffness, twitching, sweating, diarrhea)
  • Dizziness or lightheadedness, especially when standing up (may indicate low blood pressure or heart rhythm issues)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking another medication that contains the same active ingredient as this drug.
If you are taking apomorphine, as this may interact with this medication.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to discuss all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. This includes:

All prescription medications you are currently taking
Over-the-counter (OTC) medications
Natural products, such as herbal supplements
* Vitamins

You must verify that it is safe to take this medication with all of your existing medications and health conditions. Do not initiate, discontinue, or modify the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. To minimize potential risks, avoid using heating pads or other heating devices on the area where the medication is applied. Additionally, limit your exposure to the sun, sunlamps, and tanning beds, as this medication may be less effective or cause skin irritation under these conditions. To protect your skin, keep the patch covered with clothing and cover the area where the patch was applied for 10 days after removal. Consult your doctor for further guidance. Until you understand how this medication affects you, be cautious when driving or engaging in activities that require your full attention. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential benefits and risks of this medication with your doctor to make an informed decision about its use.
🆘

Overdose Information

Overdose Symptoms:

  • Headache
  • Dizziness
  • Lightheadedness
  • Hypotension (low blood pressure)
  • QT prolongation (may not be symptomatic but can lead to arrhythmias)

What to Do:

There is no specific antidote for granisetron overdose. Management should be supportive and symptomatic. Monitor vital signs, ECG, and provide general supportive care. Call 1-800-222-1222 (Poison Control).

Drug Interactions

🔴

Major Interactions

  • Apomorphine (increased risk of severe hypotension and loss of consciousness)
🟡

Moderate Interactions

  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, MAOIs, mirtazapine, fentanyl, lithium, tramadol, triptans) - increased risk of serotonin syndrome.
  • Drugs that prolong QT interval (e.g., antiarrhythmics, antipsychotics, macrolide antibiotics, fluoroquinolones) - additive QT prolongation risk.
âš ī¸

Confidence Interactions

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient history for risk factors of QT prolongation (e.g., congenital long QT syndrome, electrolyte abnormalities, concomitant medications)

Rationale: Granisetron can prolong the QT interval, increasing risk of Torsade de Pointes.

Timing: Prior to initiation of therapy.

Electrolyte levels (potassium, magnesium)

Rationale: Hypokalemia or hypomagnesemia can increase the risk of QT prolongation.

Timing: Prior to initiation of therapy, especially in patients at risk.

📊

Routine Monitoring

Effectiveness in controlling nausea and vomiting

Frequency: Daily during chemotherapy and patch wear

Target: Absence or significant reduction of nausea and vomiting

Action Threshold: If nausea/vomiting persists or worsens, consider alternative or adjunctive antiemetic therapy.

Application site reactions (e.g., erythema, pruritus, irritation)

Frequency: Daily

Target: Minimal to no reaction

Action Threshold: Severe or persistent reactions may require patch removal and alternative antiemetic.

Signs/symptoms of Serotonin Syndrome (e.g., mental status changes, autonomic instability, neuromuscular abnormalities)

Frequency: Regularly, especially if co-administered with other serotonergic drugs

Target: Absence of symptoms

Action Threshold: Discontinue granisetron and other serotonergic agents if symptoms occur.

đŸ‘ī¸

Symptom Monitoring

  • Nausea
  • Vomiting
  • Headache
  • Constipation
  • Diarrhea
  • Dizziness
  • Application site reactions (redness, itching, irritation)
  • Signs of serotonin syndrome (agitation, hallucinations, rapid heart beat, fever, overactive reflexes, nausea, vomiting, diarrhea, muscle rigidity, tremor, incoordination)

Special Patient Groups

🤰

Pregnancy

Category B. Animal studies have not shown harm to the fetus, but there are no adequate and well-controlled studies in pregnant women. Use only if clearly needed and the potential benefit outweighs the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: Low risk based on animal data, but human data are lacking.
Second Trimester: Low risk based on animal data, but human data are lacking.
Third Trimester: Low risk based on animal data, but human data are lacking.
🤱

Lactation

It is not known whether granisetron is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: Risk unknown; potential for adverse effects. Caution advised.
đŸ‘ļ

Pediatric Use

Safety and effectiveness of Sancuso transdermal system have not been established in pediatric patients.

👴

Geriatric Use

No dosage adjustment is necessary for elderly patients. Clinical studies did not identify differences in safety or efficacy between elderly and younger patients.

Clinical Information

💎

Clinical Pearls

  • Sancuso patch offers a convenient, sustained-release option for CINV prevention, particularly useful for patients who may have difficulty with oral medications or require prolonged antiemetic coverage.
  • Ensure proper application technique (clean, dry, intact skin on upper outer arm, rotate sites) to optimize absorption and minimize skin irritation.
  • Advise patients to avoid external heat sources over the patch, as this can increase drug release and systemic exposure.
  • While no dose adjustment is needed for renal or hepatic impairment, monitor patients with underlying cardiac conditions or electrolyte imbalances due to the potential for QT prolongation.
🔄

Alternative Therapies

  • Oral granisetron (Kytril)
  • IV granisetron
  • Oral ondansetron (Zofran)
  • IV ondansetron
  • Oral palonosetron (Aloxi)
  • IV palonosetron
  • Netupitant/palonosetron (Akynzeo) - oral or IV
  • Rolapitant (Varubi) - oral or IV
  • Aprepitant (Emend) - oral or IV
  • Fosaprepitant (Emend) - IV
  • Dexamethasone
💰

Cost & Coverage

Average Cost: $1000 - $1500 per patch
Generic Available: Yes
Insurance Coverage: Tier 3 or Specialty Tier (requires prior authorization)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.